SEC Form 4 · accession 0001209191-17-033760
ADURO BIOTECH, INC. · ADRO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Blaine Templeman
Officer — Executive VP, General Counsel
Period of report
May 17, 2017
Accepted (ET)
May 18, 2017 · 8:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001435049
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | May 17, 2017 | S | 1,648 | $9.65 | D | 37,300 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported in this Form 4 were affected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2016.
- F2Includes 1,648 shares acquired by the Reporting Person on May 15, 2017 under the Issuer's 2015 Employee Stock Purchase Plan.